A 66-year-old man with newly diagnosed non-valvular atrial fibrillation is reviewed in clinic. He has a history of well-controlled hypertension but no diabetes, prior stroke or vascular disease. He has normal renal function and no history of bleeding. According to the Australian atrial fibrillation guidelines, using the sexless CHA2DS2-VA score, what is the most appropriate stroke prevention strategy?